Annular leukocytoclastic vasculitis associated with anti-tuberculosis medications: a case report
نویسندگان
چکیده
منابع مشابه
Annular leukocytoclastic vasculitis associated with anti-tuberculosis medications: a case report
INTRODUCTION Anti-tuberculosis drug-induced cutaneous leukocytoclastic vasculitis has been rarely reported. To the best of our knowledge, this is the first reported case of annular leukocytoclastic vasculitis associated with anti-tuberculosis drug administration. CASE PRESENTATION We report a case of annular leukocytoclastic vasculitis induced by anti-tuberculosis medication. A 62-year-old Th...
متن کاملCutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment
lamina propria (Figure 2B). The autoantibodies were not significantly increased. Anti-tuberculosis treatment was stopped, and the patient was started on methylprednisolone. This treatment relieved his skin lesions, abdominal pain. Follow-up esophagogastroduodenoscopy showed complete disappearance of all mucosal lesions. The patient fully met the criteria for CLV, as he was >16 years of age and ...
متن کاملAnnular Leukocytoclastic Vasculitis in a Patient with Ulcerative Colitis
Leukocytoclastic vasculitis (LV) is characterized by neutrophilic invasion and fibrinoid necrosis along with endothelial enlargement in postcapillary venules. Annular appearance of LV (ALV) is rare, but it can be accompanied by several systemic diseases. One of these systemic diseases is ulcerative colitis (UC), a subgroup of inflammatory bowel disease. Only one case was previously reported in ...
متن کاملCutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide
Anti-tuberculosis drugs frequently result in cutaneous adverse reactions, including pruritus, maculopapular exanthems, and urticaria. However, anti-tuberculosis drug-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampin and pyrazinamide. A 38-year-old male had been diagnosed with pulmonary tuberculosis two months ago and t...
متن کاملVancomycin-Associated Leukocytoclastic Vasculitis
Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Medical Case Reports
سال: 2013
ISSN: 1752-1947
DOI: 10.1186/1752-1947-7-34